The burgeoning landscape of medication for obesity and type 2 metabolic disorder is currently witnessing considerable attention surrounding both retatrutide and tirzepatide. While both represent novel dual GIP and https://lewysfuan726134.ampblogs.com/retatrutide-vs-tirzepatide-a-comparative-analysis-75643382